PubMed · 8923599
Cardiac involvement in scleroderma.
Abstract
In summary, cardiac involvement in systemic sclerosis can be manifested as myocardial disease, pericardial disease, conduction system disease, or arrhythmias. Clinical cardiac involvement is a poor prognostic factor. Asymptomatic cardiac abnormalities are frequent, and all cardiac abnormalities are seen more often in diffuse scleroderma. Unlike other organs, the role of vascular involvement is unclear. At present, treatment of cardiac scleroderma is essentially symptomatic and empiric. The role of vasodilation and immunosuppression needs further exploration.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A Deswal, W P Follansbee. 1996. Cardiac involvement in scleroderma.. https://doi.org/10.1016/s0889-857x(05)70304-5. https://pubmed.health/record/pubmed%3A8923599/cardiac-involvement-in-scleroderma
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.